UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 254

Sortiert nach

Is smallpox vaccination protective against human monkeypox?

Journal of medical virology, 2023-01, Vol.95 (1), p.e28077-n/a

2023

Volltextzugriff (PDF)

Switch to Dolutegravir plus Rilpivirine Dual Therapy in cART-Experienced Subjects: An Observational Cohort

PloS one, 2016-10, Vol.11 (10), p.e0164753

2016

Volltextzugriff (PDF)

Immunogenicity and Safety of the 13-Valent Pneumococcal Conjugate Vaccine versus the 23-Valent Polysaccharide Vaccine in Unvaccinated HIV-Infected Adults: A Pilot, Prospective Controlled Study

PloS one, 2016-06, Vol.11 (6), p.e0156523-e0156523

2016

Volltextzugriff (PDF)

Ventilator-associated pneumonia (VAP) and pleural empyema caused by multidrug-resistant Acinetobacter baumannii in HIV and COVID 19 infected patient: A case report

Infectious medicine, 2023-06, Vol.2 (2), p.143-147

2023

Volltextzugriff (PDF)

Off‐label use of tocilizumab in patients with SARS‐CoV‐2 infection

Journal of medical virology, 2020-10, Vol.92 (10), p.1787-1788

2020

Volltextzugriff (PDF)

Budget impact analysis of the simplification to atazanavir + ritonavir + lamivudine dual therapy of HIV-positive patients receiving atazanavir-based triple therapies in Italy starting from data of the Atlas-M trial

ClinicoEconomics and outcomes research, 2017-03, Vol.9, p.173-179

2017

Volltextzugriff (PDF)

Neutrophil-to-lymphocyte ratio and clinical outcome in COVID-19: a report from the Italian front line

International journal of antimicrobial agents, 2020-08, Vol.56 (2), p.106017-106017, Article 106017

2020

Volltextzugriff (PDF)

Are we really ready for dual therapy in naive people with HIV? The experience from a large university hospital in Rome, Italy

Journal of antimicrobial chemotherapy, 2024-02, Vol.79 (2), p.473-475

2024

Volltextzugriff (PDF)

Update of the budget impact analysis of the simplification to atazanavir + ritonavir + lamivudine dual therapy of HIV-positive patients receiving atazanavir-based triple therapies in Italy starting from data of the Atlas-M trial

ClinicoEconomics and outcomes research, 2017, Vol.9, p.569-571

2017

Volltextzugriff (PDF)

Rapid improvement of severe Mpox lesions with oral tecovirimat

Journal of medical virology, 2023-06, Vol.95 (6), p.e28825-n/a

2023

Volltextzugriff (PDF)

COVID‐19 diagnosis does not rule out other concomitant diseases

European journal of clinical investigation, 2020-06, Vol.50 (6), p.e13241-n/a

2020

Volltextzugriff (PDF)

Early use of tecovirimat in a young man with severe mpox skin lesions: a case report

Journal of medical virology, 2023-02, Vol.95 (2), p.e28528-n/a

2023

Volltextzugriff (PDF)

Sexually transmitted infections in people with multidrug-resistant HIV

AIDS (London), 2023-12, Vol.37 (15), p.2425

2023

Volltextzugriff (PDF)

Necrotizing mpox with persistent microbiological positivity despite the use of tecovirimat: A case report

Travel medicine and infectious disease, 2024-09, Vol.61, p.102746, Article 102746

2024

Volltextzugriff (PDF)

Comparative determination of HIV-1 co-receptor tropism by Enhanced Sensitivity Trofile, gp120 V3-loop RNA and DNA genotyping

Retrovirology, 2010-06, Vol.7 (1), p.56-56, Article 56

2010

Volltextzugriff (PDF)

Five Years With Dolutegravir Plus Lamivudine as a Switch Strategy: Much More Than a Positive Finding

Journal of acquired immune deficiency syndromes (1999), 2021-11, Vol.88 (3), p.234

2021

Volltextzugriff (PDF)

HIV and vicarious stigma in a cohort of people living with HIV in Italy: What happens when the stigma is fueled by healthcare providers?

AIDS care, 2024-10, Vol.36 (10), p.1441-1451

2024

Volltextzugriff (PDF)

Treatment Experienced People Living With HIV switching to DOR/3TC/TDF in Outpatient Setting: Real-World Data on Tolerability and Cost Savings From an Italian Multicenter Cohort

Journal of acquired immune deficiency syndromes (1999), 2024-06, Vol.96 (2), p.e10

2024

Volltextzugriff (PDF)

Are we ready for long‐acting? A feasibility evaluation of long‐acting cabotegravir–rilpivirine in clinical practice

Journal of medical virology, 2022-10, Vol.94 (10), p.4970-4974

2022

Volltextzugriff (PDF)

A comparison between two dolutegravir-based two-drug regimens as switch strategies in a multicentre cohort of HIV-1-infected patients

Antiviral therapy, 2019, Vol.24 (1), p.63-67

2019

Volltextzugriff (PDF)

Clinical presentation of human monkeypox virus infection during the 2022 outbreak: descriptive case series from a large italian Research Hospital

Virology journal, 2023-09, Vol.20 (1), p.214-214, Article 214

2023

Volltextzugriff (PDF)

Quantification of Total HIV DNA as a Marker to Measure Viral Reservoir: Methods and Potential Implications for Clinical Practice

Diagnostics (Basel), 2021-12, Vol.12 (1), p.39

2021

Volltextzugriff (PDF)

‘How much raltegravir do you take?’ The answer may not be so obvious: an accidental finding from clinical practice

HIV medicine, 2020-02, Vol.21 (2), p.e1-e2

2020

Volltextzugriff (PDF)

Efficacy and durability of two‐ vs. three‐drug integrase inhibitor‐based regimens in virologically suppressed HIV‐infected patients: Data from real‐life ODOACRE cohort

HIV medicine, 2021-10, Vol.22 (9), p.843-853

2021

Volltextzugriff (PDF)

Characteristics of mental health interventions in a cohort of Italian PLWH over the last five years: impact of HIV disease and outbreak of COVID-19 pandemic

Psychology, health & medicine, 2023-10, Vol.28 (9), p.2562-2578

2023

Volltextzugriff (PDF)

1 – 25 von 254

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(244)
Mit Volltextzugriff
(216)

Publikationsform

Artikel
(249)
Berichte
(5)

Sprache

Englisch
(253)
Japanisch
(11)
Russisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Is smallpox vaccination protective against human monkeypox?

Switch to Dolutegravir plus Rilpivirine Dual Therapy in cART-Experienced Subjects: An Observational Cohort

Immunogenicity and Safety of the 13-Valent Pneumococcal Conjugate Vaccine versus the 23-Valent Polysaccharide Vaccine in Unvaccinated HIV-Infected Adults: A Pilot, Prospective Controlled Study

Ventilator-associated pneumonia (VAP) and pleural empyema caused by multidrug-resistant Acinetobacter baumannii in HIV and COVID 19 infected patient: A case report

Off‐label use of tocilizumab in patients with SARS‐CoV‐2 infection

Budget impact analysis of the simplification to atazanavir + ritonavir + lamivudine dual therapy of HIV-positive patients receiving atazanavir-based triple therapies in Italy starting from data of the Atlas-M trial

Neutrophil-to-lymphocyte ratio and clinical outcome in COVID-19: a report from the Italian front line

Are we really ready for dual therapy in naive people with HIV? The experience from a large university hospital in Rome, Italy

Update of the budget impact analysis of the simplification to atazanavir + ritonavir + lamivudine dual therapy of HIV-positive patients receiving atazanavir-based triple therapies in Italy starting from data of the Atlas-M trial

Rapid improvement of severe Mpox lesions with oral tecovirimat

COVID‐19 diagnosis does not rule out other concomitant diseases

Early use of tecovirimat in a young man with severe mpox skin lesions: a case report

Sexually transmitted infections in people with multidrug-resistant HIV

Necrotizing mpox with persistent microbiological positivity despite the use of tecovirimat: A case report

Comparative determination of HIV-1 co-receptor tropism by Enhanced Sensitivity Trofile, gp120 V3-loop RNA and DNA genotyping

Five Years With Dolutegravir Plus Lamivudine as a Switch Strategy: Much More Than a Positive Finding

HIV and vicarious stigma in a cohort of people living with HIV in Italy: What happens when the stigma is fueled by healthcare providers?

Treatment Experienced People Living With HIV switching to DOR/3TC/TDF in Outpatient Setting: Real-World Data on Tolerability and Cost Savings From an Italian Multicenter Cohort

Are we ready for long‐acting? A feasibility evaluation of long‐acting cabotegravir–rilpivirine in clinical practice

A comparison between two dolutegravir-based two-drug regimens as switch strategies in a multicentre cohort of HIV-1-infected patients

Clinical presentation of human monkeypox virus infection during the 2022 outbreak: descriptive case series from a large italian Research Hospital

Quantification of Total HIV DNA as a Marker to Measure Viral Reservoir: Methods and Potential Implications for Clinical Practice

‘How much raltegravir do you take?’ The answer may not be so obvious: an accidental finding from clinical practice

Efficacy and durability of two‐ vs. three‐drug integrase inhibitor‐based regimens in virologically suppressed HIV‐infected patients: Data from real‐life ODOACRE cohort

Characteristics of mental health interventions in a cohort of Italian PLWH over the last five years: impact of HIV disease and outbreak of COVID-19 pandemic

Suchergebnisse filtern